Advertisement
Screener

LIFECORE BIOMEDICAL, INC. (LFCR) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

LIFECORE BIOMEDICAL, INC. Stock-Based Compensation

LIFECORE BIOMEDICAL, INC. (LFCR) reported Stock-Based Compensation of $3.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-05

  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $2.08M.
  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.70M.
  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.39M.
  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-05-25 was $1.81M, a 13.58% increase year-over-year.
  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $10.16M, a 63.81% increase from fiscal 2024.
  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $6.20M, a 71.68% increase from fiscal 2023.
  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $3.61M, a 38.50% increase from fiscal 2022.
  • LIFECORE BIOMEDICAL, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $2.61M, a 22.38% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 7 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 month
2026-06-30$2.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$3.78M
10-Q · filed 2026-08-05
2026-03-31$1.70M
10-Q · filed 2026-05-06
2025-12-31$5.67M
10-KT · filed 2026-03-16
2025-09-30$2.39M
10-Q · filed 2025-11-06
2025-05-25$1.81M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$4.37M
10-Q · filed 2026-08-05
$7.74M
derived: sum of 3 quarters · filed 2026-08-05
$10.16M
10-KT · filed 2026-03-16
2025-02-23$2.55M
10-Q · filed 2026-05-06
$5.92M
derived: sum of 2 quarters · filed 2026-05-06
$8.34M
10-Q · filed 2025-04-03
$9.94M
derived: sum of 4 quarters · filed 2026-05-06
2024-11-24$3.37M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02
$5.79M
10-Q · filed 2025-01-02
$7.39M
derived: sum of 3 quarters · filed 2026-03-16
$8.88M
derived: sum of 4 quarters · filed 2026-03-16
2024-08-25$2.42M
10-Q · filed 2025-11-06
$4.02M
derived: sum of 2 quarters · filed 2026-03-16
$5.51M
derived: sum of 3 quarters · filed 2026-03-16
$7.09M
derived: sum of 4 quarters · filed 2026-03-16
2024-05-26$1.60M
derived: 10-KT 12 month − 10-Q 9 month · filed 2026-03-16
$3.09M
derived: sum of 2 quarters · filed 2026-03-16
$4.67M
derived: sum of 3 quarters · filed 2026-03-16
$6.20M
10-KT · filed 2026-03-16
2024-02-25$1.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-03
$3.07M
derived: sum of 2 quarters · filed 2025-04-03
$4.60M
10-Q · filed 2025-04-03
$5.42M
derived: sum of 4 quarters · filed 2025-04-03
2023-11-26$1.58M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-02
$3.11M
10-Q · filed 2025-01-02
$3.93M
derived: sum of 3 quarters · filed 2025-01-02
$4.83M
derived: sum of 4 quarters · filed 2025-01-02
2023-08-27$1.53M
10-Q · filed 2024-10-04
$2.35M
derived: sum of 2 quarters · filed 2024-10-04
$3.25M
derived: sum of 3 quarters · filed 2024-10-04
$4.36M
derived: sum of 4 quarters · filed 2024-10-04
2023-05-28$816.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26
$1.72M
derived: sum of 2 quarters · filed 2024-08-26
$2.83M
derived: sum of 3 quarters · filed 2024-08-26
$3.61M
10-K · filed 2024-08-26
2023-02-26$903.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09
$2.01M
derived: sum of 2 quarters · filed 2024-08-09
$2.80M
10-Q · filed 2024-08-09
$3.48M
derived: sum of 4 quarters · filed 2024-08-26
2022-11-27$1.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
$1.89M
10-Q · filed 2024-08-09
$2.57M
derived: sum of 3 quarters · filed 2024-08-26
$3.19M
derived: sum of 4 quarters · filed 2024-08-26
2022-08-28$785.00K
10-Q · filed 2024-08-09
$1.47M
derived: sum of 2 quarters · filed 2024-08-26
$2.09M
derived: sum of 3 quarters · filed 2024-08-26
$2.77M
derived: sum of 4 quarters · filed 2024-08-26
2022-05-29$680.00K
derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26
$1.30M
derived: sum of 2 quarters · filed 2024-08-26
$1.99M
derived: sum of 3 quarters · filed 2024-08-26
$2.61M
10-K · filed 2024-08-26
2022-02-27$622.00K
derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20
$1.31M
derived: sum of 2 quarters · filed 2024-03-20
$1.93M
10-K · filed 2024-03-20
$2.70M
derived: sum of 4 quarters · filed 2024-03-20
2021-11-28$686.00K
derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20
$1.31M
10-K · filed 2024-03-20
$2.08M
derived: sum of 3 quarters · filed 2024-03-20
$2.88M
derived: sum of 4 quarters · filed 2024-03-20
2021-08-29$620.00K
10-K · filed 2024-03-20
$1.40M
derived: sum of 2 quarters · filed 2024-03-20
$2.19M
derived: sum of 3 quarters · filed 2024-03-20
$3.09M
derived: sum of 4 quarters · filed 2024-03-20
2021-05-30$776.00K
derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20
$1.57M
derived: sum of 2 quarters · filed 2024-03-20
$2.47M
derived: sum of 3 quarters · filed 2024-03-20
$3.36M
10-K · filed 2024-03-20
2021-02-28$797.00K
derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20
$1.69M
derived: sum of 2 quarters · filed 2024-03-20
$2.58M
10-K · filed 2024-03-20
$3.12M
derived: sum of 4 quarters · filed 2024-03-20
2020-11-29$895.00K
derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07
$1.79M
10-Q · filed 2022-01-07
$2.33M
derived: sum of 3 quarters · filed 2024-03-20
$2.89M
derived: sum of 4 quarters · filed 2024-03-20
2020-08-30$892.00K
10-K · filed 2024-03-20
$1.43M
derived: sum of 2 quarters · filed 2024-03-20
$2.00M
derived: sum of 3 quarters · filed 2024-03-20
$2.78M
derived: sum of 4 quarters · filed 2024-03-20
2020-05-31$538.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16
$1.10M
derived: sum of 2 quarters · filed 2023-03-16
$1.89M
derived: sum of 3 quarters · filed 2023-03-16
$2.42M
10-K/A · filed 2023-03-16
2020-02-23$566.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08
$1.35M
derived: sum of 2 quarters · filed 2021-04-08
$1.88M
10-Q · filed 2021-04-08
$2.96M
derived: sum of 4 quarters · filed 2021-07-29
2019-11-24$787.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07
$1.31M
10-Q · filed 2021-01-07
$2.39M
derived: sum of 3 quarters · filed 2021-07-29
$3.21M
derived: sum of 4 quarters · filed 2021-07-29
2019-08-25$528.00K
10-Q · filed 2020-10-07
$1.61M
derived: sum of 2 quarters · filed 2021-07-29
$2.42M
derived: sum of 3 quarters · filed 2021-07-29
$3.36M
derived: sum of 4 quarters · filed 2021-07-29
2019-05-26$1.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29
$1.89M
derived: sum of 2 quarters · filed 2021-07-29
$2.83M
derived: sum of 3 quarters · filed 2021-07-29
$3.56M
10-K · filed 2021-07-29
2019-02-24$816.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03
$1.75M
derived: sum of 2 quarters · filed 2020-04-03
$2.48M
10-Q · filed 2020-04-03
$3.67M
derived: sum of 4 quarters · filed 2020-08-14
2018-11-25$938.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02
$1.67M
10-Q · filed 2020-01-02
$2.86M
derived: sum of 3 quarters · filed 2020-08-14
$4.00M
derived: sum of 4 quarters · filed 2020-08-14
2018-08-26$728.00K
10-Q · filed 2019-10-03
$1.92M
derived: sum of 2 quarters · filed 2020-08-14
$3.06M
derived: sum of 3 quarters · filed 2020-08-14
$4.18M
derived: sum of 4 quarters · filed 2020-08-14
2018-05-27$1.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14
$2.34M
derived: sum of 2 quarters · filed 2020-08-14
$3.45M
derived: sum of 3 quarters · filed 2020-08-14
$4.40M
10-K · filed 2020-08-14
2018-02-25$1.15M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04
$2.26M
derived: sum of 2 quarters · filed 2019-04-04
$3.21M
10-Q · filed 2019-04-04
$4.33M
derived: sum of 4 quarters · filed 2019-08-01
2017-11-26$1.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07
$2.07M
10-Q · filed 2019-01-07
$3.19M
derived: sum of 3 quarters · filed 2019-08-01
$4.26M
derived: sum of 4 quarters · filed 2019-08-01
2017-08-27$950.00K
10-Q · filed 2018-10-05
$2.07M
derived: sum of 2 quarters · filed 2019-08-01
$3.14M
derived: sum of 3 quarters · filed 2019-08-01
$4.11M
derived: sum of 4 quarters · filed 2019-08-01
2017-05-28$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01
$2.19M
derived: sum of 2 quarters · filed 2019-08-01
$3.16M
derived: sum of 3 quarters · filed 2019-08-01
$3.96M
10-K · filed 2019-08-01
2017-02-26$1.07M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05
$2.04M
derived: sum of 2 quarters · filed 2018-04-05
$2.84M
10-Q · filed 2018-04-05
$3.73M
derived: sum of 4 quarters · filed 2018-08-09
2016-11-27$966.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05
$1.77M
10-Q · filed 2018-01-05
$2.66M
derived: sum of 3 quarters · filed 2018-08-09
$3.54M
derived: sum of 4 quarters · filed 2018-08-09
2016-08-28$807.00K
10-Q · filed 2017-09-28
$1.69M
derived: sum of 2 quarters · filed 2018-08-09
$2.58M
derived: sum of 3 quarters · filed 2018-08-09
$3.48M
derived: sum of 4 quarters · filed 2018-08-09
2016-05-29$884.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09
$1.77M
derived: sum of 2 quarters · filed 2018-08-09
$2.67M
derived: sum of 3 quarters · filed 2018-08-09
$3.46M
10-K · filed 2018-08-09
2016-02-28$884.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07
$1.78M
derived: sum of 2 quarters · filed 2017-04-07
$2.58M
10-Q · filed 2017-04-07
$3.02M
derived: sum of 4 quarters · filed 2018-03-15
2015-11-29$900.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05
$1.70M
10-Q · filed 2017-01-05
$2.13M
derived: sum of 3 quarters · filed 2018-03-15
$2.53M
derived: sum of 4 quarters · filed 2018-03-15
2015-08-30$797.00K
10-Q · filed 2016-09-29
$1.24M
derived: sum of 2 quarters · filed 2018-03-15
$1.63M
derived: sum of 3 quarters · filed 2018-03-15
$1.98M
derived: sum of 4 quarters · filed 2018-03-15
2015-05-31$438.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15
$829.00K
derived: sum of 2 quarters · filed 2018-03-15
$1.18M
derived: sum of 3 quarters · filed 2018-03-15
$1.58M
10-K/A · filed 2018-03-15
2015-03-01$391.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30
$741.00K
derived: sum of 2 quarters · filed 2016-03-30
$1.14M
10-Q · filed 2016-03-30
$1.50M
derived: sum of 4 quarters · filed 2016-08-01
2014-11-30$350.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07
$748.00K
10-Q · filed 2016-01-07
$1.11M
derived: sum of 3 quarters · filed 2016-08-01
$1.47M
derived: sum of 4 quarters · filed 2016-08-01
2014-08-31$398.00K
10-Q · filed 2015-10-01
$762.00K
derived: sum of 2 quarters · filed 2016-08-01
$1.11M
derived: sum of 3 quarters · filed 2016-08-01
$1.48M
derived: sum of 4 quarters · filed 2016-08-01
2014-05-25$364.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01
$717.00K
derived: sum of 2 quarters · filed 2016-08-01
$1.08M
derived: sum of 3 quarters · filed 2016-08-01
$1.36M
10-K · filed 2016-08-01
2014-02-23$353.00K
10-Q · filed 2014-03-28
$714.00K
derived: sum of 2 quarters · filed 2014-03-28
$992.00K
10-Q · filed 2015-04-02
$1.55M
derived: sum of 4 quarters · filed 2015-07-31
2013-11-24$361.00K
10-Q · filed 2014-01-03
$639.00K
10-Q · filed 2015-01-09
$1.20M
derived: sum of 3 quarters · filed 2015-07-31
$1.66M
derived: sum of 4 quarters · filed 2015-07-31
2013-08-25$278.00K
10-Q · filed 2014-10-08
$838.00K
derived: sum of 2 quarters · filed 2015-07-31
$1.30M
derived: sum of 3 quarters · filed 2015-07-31
$1.63M
derived: sum of 4 quarters · filed 2015-07-31
2013-05-26$560.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31
$1.02M
derived: sum of 2 quarters · filed 2015-07-31
$1.35M
derived: sum of 3 quarters · filed 2015-07-31
$1.70M
10-K · filed 2015-07-31
2013-02-24$464.00K
10-Q · filed 2014-03-28
$787.00K
derived: sum of 2 quarters · filed 2014-03-28
$1.14M
10-Q · filed 2014-03-28
2012-11-25$323.00K
10-Q · filed 2014-01-03
$671.00K
10-Q · filed 2014-01-03
2012-08-28$441.00K
10-Q/A · filed 2013-01-02
2012-08-26$348.00K
10-Q · filed 2013-09-26
$906.00K
derived: sum of 2 quarters · filed 2014-08-01
$1.33M
derived: sum of 3 quarters · filed 2014-08-01
$1.78M
derived: sum of 4 quarters · filed 2014-08-01
2012-05-27$558.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01
$987.00K
derived: sum of 2 quarters · filed 2014-08-01
$1.43M
derived: sum of 3 quarters · filed 2014-08-01
$1.87M
10-K · filed 2014-08-01
2012-02-26$429.00K
10-Q · filed 2013-04-04
$873.00K
derived: sum of 2 quarters · filed 2013-04-04
$1.31M
10-Q · filed 2013-04-04
$1.87M
derived: sum of 4 quarters · filed 2013-08-07
2011-11-27$444.00K
10-Q · filed 2013-01-04
$885.00K
10-Q · filed 2013-01-04
$1.44M
derived: sum of 3 quarters · filed 2013-08-07
2011-08-28$441.00K
10-Q/A · filed 2013-01-02
$994.00K
derived: sum of 2 quarters · filed 2013-08-07
2011-05-29$553.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07
$1.95M
10-K · filed 2013-08-07
2011-02-27$1.40M
10-Q · filed 2012-03-28
2010-11-28$962.00K
10-Q · filed 2012-01-05
2010-08-29$506.00K
10-Q · filed 2011-10-05
2010-05-30$1.02M
10-K · filed 2012-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ADC Therapeutics SA (ADCT)$0.163B-1.39
Minerva Neurosciences, Inc. (NERV)United States$0.165B-0.66
Tonix Pharmaceuticals Holding Corp. (TNXP)United States$0.166B-1.34
Annexon, Inc. (ANNX)United States$0.147B-4.22
Corbus Pharmaceuticals Holdings, Inc. (CRBP)United States$0.144B-1.72
Organogenesis Holdings Inc. (ORGO)United States$0.182B-3.70
SPRUCE BIOSCIENCES, INC. (SPRB)United States$0.142B-2.89
Korro Bio, Inc. (KRRO)United States$0.141B-1.81
AN2 Therapeutics, Inc. (ANTX)United States$0.185B-4.84
Atrium Therapeutics, Inc. (RNA)United States$0.140B